Professor Philip Hill
| Position | McAuley Professor of International Health |
|---|---|
| Department | Department of Preventive and Social Medicine (DSM) |
| Qualifications | BHB MB ChB MPH MD FRACP FAFPHM FNZCPHM |
| Research summary | International health |
Research
Professor Philip Hill holds separate qualifications as a medical practitioner (MBChB), specialist public health physician (FAFPHM), specialist infectious diseases physician (FRACP), as well as a doctorate in the epidemiology of tuberculosis in The Gambia (MD).
After completing specialty training in New Zealand, he spent 6 years working as a clinical epidemiologist for the MRC Laboratories in The Gambia. There he led the tuberculosis research group and was the lead clinical epidemiologist on the pneumococcal projects.
Professor Hill is the first holder of the McAuley Chair in International Health and is Founding Director and Co-Director of the Centre for International Health at the University of Otago. He is involved in research projects in Africa, Asia, Europe, South America, and the Pacific. In 2008 he established the Otago International Health Research Network of over 100 researchers across all four divisions of the university, with an interest in health research in Low and Middle Income Countries. This network has been renamed the Otago Global Health Institute and is now one of 12 flagship research centres of the University.
Professor Hill has published over 160 articles in peer reviewed journals. His research interests include studies of Mycobacterium tuberculosis infection and disease, and Streptococcus pneumoniae carriage, disease, and vaccination. He is also interested in using epidemiological tools to answer fundamental public health questions in Low and Middle Income countries, including the relationship of the quality of health systems to key health outcomes in both communicable and non-communicable diseases.
Professor Hill has been a Lead or co-Investigator on grants worth more than $30 million since 2001, including from the Bill & Melinda Gates Foundation, MRC(UK), European Commission, DFID (UK), The Canadian Institute of Medical Research, the New Zealand Health Research Council, and Global Fund.
He has a special interest in training people from Low and Middle Income Countries at Masters and PhD level, with a view to them becoming internationally competitive academic leaders back in their home country. He has supervised over 15 Masters and over 15 PhD students, who have had a 100% completion rate. He welcomes new enquiries from prospective students.
Publications
Adetifa, I. M. O., Ota, M. O. C., Jeffries, D. J., Lugos, M. D., Hammond, A. S., Battersby, N. J., … Hill, P. C. (2013). Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: A clinical trial. American Journal of Respiratory & Critical Care Medicine, 187(4), 439-445. doi: 10.1164/rccm.201208-1352OC
MacKenzie, G. A., Plumb, I. D., Sambou, S., Saha, D., Uchendu, U., Akinsola, B., … Hill, P. C. (2012). Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: Design and implementation of a population-based surveillance system. PLoS Medicine, 9(1), e1001161. doi: 10.1371/journal.pmed.1001161
Rutherford, M. E., Ruslami, R., Anselmo, M., Alisjahbana, B., Yulianti, N., Sampurno, H., … Hill, P. C. (2013). Management of children exposed to Mycobacterium tuberculosis: A public health evaluation in West Java, Indonesia. Bulletin of the World Health Organization, 91(12), 932-941. doi: 10.2471/BLT.13.118414
Egere, U., Townend, J., Roca, A., Akinsanya, A., Bojang, A., Nsekpong, D., … Hill, P. C. (2012). Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: A randomised controlled trial. PLoS ONE, 7(11), e49143. doi: 10.1371/journal.pone.0049143
Walsh, M. S., Hope, E., Isaia, L., Righarts, A., Niupulusu, T., Temese, S. V. A., … Edwards, C., Wernick, M., … Hill, P. C. (2015). Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: A community-based study. Transactions of the Royal Society of Tropical Medicine & Hygiene, 109, 245-251. doi: 10.1093/trstmh/trv014
Journal - Research Article
Walsh, M. S., Hope, E., Isaia, L., Righarts, A., Niupulusu, T., Temese, S. V. A., … Edwards, C., Wernick, M., … Hill, P. C. (2015). Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: A community-based study. Transactions of the Royal Society of Tropical Medicine & Hygiene, 109, 245-251. doi: 10.1093/trstmh/trv014
Hill, P. C., Dye, C., Viney, K., Tabutoa, K., Kienene, T., Bissell, K., … Harries, A. D. (2014). Mass treatment to eliminate tuberculosis from an island population. International Journal of Tuberculosis & Lung Disease, 18(8), 899-904. doi: 10.5588/ijtld.14.0007
Howie, S. R. C., Morris, G. A. J., Tokarz, R., Ebruke, B. E., Machuka, E. M., Ideh, R. C., … Hill, P. C., … Adegbola, R. A. (2014). Etiology of severe childhood pneumonia in The Gambia, West Africa, determined by conventional and molecular microbiological analyses of lung and pleural aspirate samples. Clinical Infectious Diseases, 59(5), 682-685. doi: 10.1093/cid/ciu384
Jacobs, C., Chiluba, C., Phiri, C., Lisulo, M. M., Chomba, M., Hill, P. C., … Kelly, P. (2014). Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: Strong association with HIV and environmental enteropathy. Journal of Infectious Diseases, 209(5), 652-657. doi: 10.1093/infdis/jit409
Bottomley, C., Roca, A., Hill, P. C., Greenwood, B., & Isham, V. (2013). A mathematical model of serotype replacement in pneumococcal carriage following vaccination. Journal of the Royal Society Interface, 10(89), 20130786. doi: 10.1098/rsif.2013.0786
Rutherford, M. E., Hill, P. C., Maharani, W., Sampurno, H., & Ruslami, R. (2013). Risk factors for treatment default among adult tuberculosis patients in Indonesia. International Journal of Tuberculosis & Lung Disease, 17(10), 1304-1309. doi: 10.5588/ijtld.13.0084
Adetifa, I. M. O., Ota, M. O. C., Jeffries, D. J., Lugos, M. D., Hammond, A. S., Battersby, N. J., … Hill, P. C. (2013). Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: A clinical trial. American Journal of Respiratory & Critical Care Medicine, 187(4), 439-445. doi: 10.1164/rccm.201208-1352OC
Saha, D., Akinsola, A., Sharples, K., Adeyemi, M. O., Antonio, M., Imran, S., … Hill, P. C. (2013). Health Care Utilization and Attitudes Survey: Understanding diarrheal disease in rural Gambia. American Journal of Tropical Medicine & Hygiene, 89(Suppl. 1), 13-20. doi: 10.4269/ajtmh.12-0751
Rutherford, M. E., Ruslami, R., Anselmo, M., Alisjahbana, B., Yulianti, N., Sampurno, H., … Hill, P. C. (2013). Management of children exposed to Mycobacterium tuberculosis: A public health evaluation in West Java, Indonesia. Bulletin of the World Health Organization, 91(12), 932-941. doi: 10.2471/BLT.13.118414
Roca, A., Bottomley, C., Hill, P. C., Bojang, A., Egere, U., Antonio, M., … Adegbola, R. A. (2012). Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clinical Infectious Diseases, 55(6), 816-824.
MacKenzie, G. A., Plumb, I. D., Sambou, S., Saha, D., Uchendu, U., Akinsola, B., … Hill, P. C. (2012). Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: Design and implementation of a population-based surveillance system. PLoS Medicine, 9(1), e1001161. doi: 10.1371/journal.pmed.1001161
Jack, S. J., Ou, K., Chea, M., Chhin, L., Devenish, R., Dunbar, M., … Leon de la Barra, S., Hill, P. C., Herbison, P., & Gibson, R. S. (2012). Effect of micronutrient sprinkles on reducing anemia: A cluster-randomized effectiveness trial. Archives of Pediatrics & Adolescent Medicine, 166(9), 842-850. doi: 10.1001/archpediatrics.2012.1003
Egere, U., Townend, J., Roca, A., Akinsanya, A., Bojang, A., Nsekpong, D., … Hill, P. C. (2012). Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: A randomised controlled trial. PLoS ONE, 7(11), e49143. doi: 10.1371/journal.pone.0049143
Thye, T., Owusu-Dabo, E., Vannberg, F. O., van Crevel, R., Curtis, J., Sahiratmadja, E., … Hill, P. C., … Meyer, C. G. (2012). Common variants at 11p13 are associated with susceptibility to tuberculosis. Nature Genetics, 44(3), 257-259. doi: 10.1038/ng.1080
Rutherford, M. E., Hill, P. C., Maharani, W., Apriani, L., Sampurno, H., van Crevel, R., & Ruslami, R. (2012). Risk factors for Mycobacterium tuberculosis infection in Indonesian children living with a sputum smear-positive case. International Journal of Tuberculosis & Lung Disease, 16(12), 1594-1599. doi: 10.5588/ijtld.12.0389
Rutherford, M. E., Nataprawira, M., Yulita, I., Apriani, L., Maharani, W., van Crevel, R., Hill, P. C., & Alisjahbana, B. (2012). QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case. International Journal of Tuberculosis & Lung Disease, 16(4), 496-502. doi: 10.5588/ijtld.11.0491
